CTI – CRO Specializing in Clinical Research and Consulting

CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Eurotrials, a full-service contract research organization, with more than 20 years of experience, and strong local expertise in Europe and Latin America.

We see our collaboration with Sernova on this trial in the growing field of regenerative medicine as having the potential to impact many people with diabetes, said Tim Schroeder, CEO of CTI. It is a great opportunity for CTI to collaborate with the experienced team at Sernova and allows us to continue our work in cell therapy, currently representing approximately 40% of CTIs active research programs.

Paul Ritter is a finalist in the Chief Legal Officer category, and Kevin Schwarz is a finalist in the Chief Operating Officer category.

"We are privileged to have such strong leaders on our team," remarks Tim Schroeder, CEO of CTI. "Both Paul and Kevin haveplayed crucial roles in the growth and success of our company over the last 15 years, and we are thrilled to see this well-deserved recognition from the community."

CTI is extremely happy to partner with Bexion on the development of this novel therapy in patients who desperately need alternative treatments, stated William Aronstein, PhD, MD, FACP, Vice President, Medical Affairs at CTI. They are an innovative organization with very strong regional ties the drug was initially developed and licensed at a local hospital, early funding has predominantly come from the region, and the management and board have strong local connections.

Original post:
CTI - CRO Specializing in Clinical Research and Consulting